Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Mohammed Moursi

Vascular Surgery Little Rock, AR Medical Doctor

NPI 1871504126 CMS profile 387895

4300 W 7Th St, 112Pv/Lr, Little Rock, AR 72205

Open in the dashboard

General payments

$116,048

275 records reported · program years 2019–2025

Research payments

$2,128

Paid to them · 2 records reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$200,641 paid to institutions, not to them · program years 2019–2025

Through program year 2025, Mohammed Moursi of Little Rock, AR is reported in the CMS Open Payments database as having received $116,048 across 275 general payments and $2,128 in research payments paid to them. Separately, studies naming them as principal investigator received $200,641 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 96th percentile of Vascular Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

9 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,304 11
2024 General $21,386 28
2023 General $8,844 26
2022 General $9,692 37
2022 Research $50 1
2021 General $15,866 27
2020 General $6,116 20
2020 Research $2,078 1
2019 General $52,839 126

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Mohammed Moursi
  • Vascular Surgery median
  • Middle half of Vascular Surgery
  • National median

In program year 2025, general payments to Mohammed Moursi were reported at $1,304. Among 3,991 Vascular Surgery profiles paid that year, the median was $924 and the middle half received between $273 and $2,636.

Show as a table
Year Mohammed Moursi Vascular Surgery median Middle half National median
2019 $52,839 $796 $226–$2,363 $163
2020 $6,116 $348 $118–$1,110 $114
2021 $15,866 $471 $158–$1,421 $132
2022 $9,692 $725 $222–$2,183 $149
2023 $8,844 $836 $257–$2,440 $160
2024 $21,386 $909 $252–$2,619 $164
2025 $1,304 $924 $273–$2,636 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Cook Incorporated $63,285 18 payments
  2. NuVasive, Inc. $19,398 30 payments
  3. Endologix, Inc. $15,305 36 payments
  4. Cook Medical LLC $5,455 83 payments
  5. Silk Road Medical, Inc. $4,801 12 payments
  6. W. L. Gore & Associates, Inc. $1,268 17 payments
  7. Boston Scientific Corporation $1,084 16 payments
  8. LeMaitre Vascular, Inc. $980 16 payments
  9. Penumbra, Inc. $812 6 payments
  10. Abbott Laboratories $529 6 payments
  11. Other $3,129 35 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $34,650 11 payments
  2. Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program $28,000 6 payments
  3. Consulting Fee $27,598 12 payments
  4. Food and Beverage $19,078 218 payments
  5. Travel and Lodging $6,722 28 payments
Products named General payments · program years 2019–2025
  1. Zenith Spiral-Z $24,342 15 payments
  2. Cook Medical AAA $20,547 25 payments
  3. ALIF $19,174 29 payments
  4. Cook Medical Zenith $9,890 23 payments
  5. Alto Abdominal Stent Graft System $7,019 18 payments
  6. Ovation $5,437 13 payments
  7. ENROUTE Transcarotid Stent $4,801 12 payments
  8. ENROUTE Transcarotid Neuroprotection System $4,801 12 payments
  9. Zenith $3,753 5 payments
  10. AFX2 Bifurcated Endograft System $2,456 3 payments
  11. Other $16,247 172 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Philips Electronics North America Corporation $2,078 1 payment
  2. Novo Nordisk Inc $50 1 payment

Billing to Medicare

Part B · data year 2024 · 40 billing codes

Paid by Medicare

$27,268

Medicare's payments for the services billed

Medicare patients

106

Average age 74

Services billed

203

50 women, 56 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Ischemic heart disease 55%
Arthritis 50%
Diabetes 33%
Chronic kidney disease 33%
Heart failure 32%
COPD 29%
Depression 25%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

277 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Vascular Surgery in Arkansas

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record